Format

Send to

Choose Destination
See comment in PubMed Commons below
Acta Otorrinolaringol Esp. 2005 Mar;56(3):112-5.

[Sublingual immunotherapy in seasonal allergic rhinitis. Review of 30 cases].

[Article in Spanish]

Author information

1
Servicio de Otorrinolaringología, Hospital Universitario de Getafe, Madrid. ainhoilla@yahoo.es

Abstract

INTRODUCTION:

Specific immunotherapy consists in administering increasing doses of antigen, to which the patient is sensitive, to determine a protective immune response.

PATIENTS AND METHODS:

A descriptive and retrospective review of 30 patients diagnosed of seasonal allergic rhinitis, all treated with specific immunotherapy. Data on age, gender, symptoms, prick test before and after the immunotherapy administration, drugs, efficacy and side effects, were recorded using the SPSS statistical program.

RESULTS:

90% had moderated symptoms and 10% had severe symptoms and asthma. 33% were sensitized to grass pollen. 60% needed antihistamines and intranasal corticosteroids before the immunotherapy. In a lot of cases (80%) there were no side effects. The complete desensitization occurred in 53.3% and the reduction of symptoms in 73% of the cases. 54% of the patients didn't need treatment after specific immunotherapy.

CONCLUSIONS:

The specific immunotherapy is the only curative therapy. Sublingual therapy is one of the most accepted because is well tolerated, it uses a higher allergen concentration, it reduces the symptoms and the needs of drugs and side effects are uncommon.

PMID:
15819518
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Ediciones Doyma, S.L.
    Loading ...
    Support Center